RYAH Group Inc. RYAH Archives - Page 5 of 6

FridayJul 16, 2021 11:48 am

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Brings Powerful Capabilities to Modern Clinical Trials

RYAH Group (CSE: RYAH), a health care analytics and technology company, has created IoT dose-measuring devices backed by powerful data analytics. These provide next-generation capabilities that allow for more control of variables within a clinical setting, which is especially significant in modern cannabis clinical trials. While historical emphasis has largely been centered on potential harmful effects, today’s research teams are exploring the use of cannabis to address a wide range of chronic conditions, while it holds significant potential for pain relief. The future of cannabis study with the addition of dose-measuring devises looks promising, and RYAH is front-and-center on the…

WednesdayJun 30, 2021 2:55 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Enters Strategic Partnerships to Amplify Message Through Global Expansion

RYAH Group (CSE: RYAH) today announced that it has entered into two public relations, investor relations and/or marketing arrangements. These include a service agreement with KCSA Strategic Communications, through RYAH Medtech Inc., under which KCSA will provide certain public relations and corporate communications services, as well as a service agreement with EastWest Asset Management LLC, an affiliate of CFN Media Group, through RYAH Medtech, under which EastWest will provide certain investor relations, marketing and corporate communication services to the company. “We continue to remain focused and disciplined in ensuring our clients, investors and our partners remain informed of our vision,…

FridayJun 25, 2021 2:15 pm

RYAH Group Inc. (CSE: RYAH) Cannabis Clinical Trials Improve Due to Dose-Measuring Devices

Cannabis is a chemically variable plant making its clinical trials problematic, before the creation of dose-measuring devices RYAH Smart inhalers being used in one of the largest clinical studies of its kind focused on chronic pain Restrictive funding and legislative barriers regarding cannabis are rapidly dissipating Regulating dose size in cannabis clinical trials has proven problematic from one test subject to another because cannabis is a chemically variable plant. RYAH Group (CSE: RYAH), a health care analytics and technology company, has created IoT dose-measuring devices backed by powerful data analytics, allowing for more control for variables within a clinical setting. …

WednesdayJun 23, 2021 11:51 am

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces Shipment of Proprietary Dry Herb Inhalers for Use in Pilot Program

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has completed an initial shipment of its proprietary RYAH Smart Dry Herb Inhalers. The shipment was sent to Medicann in Jersey, the largest of the Channel Islands, located between England and France. A premier cannabis-specialized clinic, Medicann plans to use the inhalers for use in a pilot program designed to collect patient feedback regarding consumption of cannabis strains that are available on the island. According to the announcement, the parties will also be…

MondayJun 21, 2021 1:44 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Partnering to Improve Standard of Care, Provide Turnkey Solutions in Plant-Based Medicine

RYAH Group (CSE: RYAH), a connected device and big data and technology company, is working with doctors as well as government and university research centers to reduce the variations in treatment plans and trials. The company, which has developed and uses dose-measuring internet-of-things (“IoT”) devices to collect HIPPA-compliant data to improve future medical treatments, is guided by the need to transform patient care. Key to this focus is utilizing big data and AI to reshape how the world understands plant-based medicine. A recent article reads, “RYAH partners with doctors to improve the standard of care for patients and researchers to…

FridayJun 18, 2021 1:47 pm

RYAH Group Inc. (CSE: RYAH) Completes First Shipment of SMART Inhalers to UK Clinical Trial

The first shipment of SMART inhalers, 10,000 cartridges and QR codes arrived in the UK for the clinic's pilot run Due to the large scale of the clinical trial, RYAH developed a custom software solution for the clinic In the UK the medical cannabis market is expected to reach $1.3 billion by 2024, and 1% of the population could be medical cannabis patients by 2028 RYAH Group (CSE: RYAH), a connected device and big data and technology company, has completed its initial shipment to a major international clinic conducting a study in the UK on the safety and efficacy of…

ThursdayJun 10, 2021 1:01 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Subsidiary Publishes Data Report on Medical Cannabis Use for Pain Management

RYAH Group (CSE: RYAH) today announced that its wholly owned subsidiary, RYAH Medtech Inc., has published a data report on the use of medical cannabis among patients with pain conditions. According to the update, the report features insights into the use of cannabis to treat pain conditions by patients within the RYAH Data ecosystem and whether cannabis may be one of the alternative treatment solutions to reduce opioid use-related problems associated with existing treatment options. “The RYAH data report on cannabis use for pain management comes at a turning point as studies on alternatives to opioids in treatment and potential…

ThursdayJun 10, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Reports on the Medical Benefits of the “Munchies”

Reported on the therapeutic benefit of munchies for nausea and vomiting Recorded over 14,500 sessions from patients seeking relief from nausea Munchies are a medical benefit for those going through chemotherapy or diagnosed with cachexia, also known as a wasting disorder RYAH Group (CSE: RYAH), the leading data technology company in plant-based medicine, collects data through its IoT dose-measuring devices and AI analytics. Recently the company reported on The Therapeutic Benefit of the Munchies for Nausea and Vomiting. The full article can be found at https://ibn.fm/mgkad. RYAH is uniquely positioned to collect essential data that can lead to more personalized…

TuesdayJun 08, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Rising Above Canada’s Medical Cannabis Growing Pains

The number of federally registered Canadians is down, but the number of users is not A large percentage of Canadians are managing their treatment without the help or oversite of a healthcare professional Retailers and product suppliers also benefit from RYAH’s suite of dose-control products, generating recurring revenue streams and strengthening their product offerings RYAH Group (CSE: RYAH), a health care analytics and technology company, has developed and uses dose-measuring IoT devices to collect HIPPA-compliant data to improve future medical treatments. The Company is working with doctors, government, and university research centers to reduce the variations in their treatment plans…

TuesdayJun 01, 2021 12:29 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Completes Initial Shipment for Major Plant-Based Medicine Trial

RYAH Group (CSE: RYAH) today announced that it has completed the first shipment of the RYAH Smart Dry Herb Inhalers, which includes a delivery of approximately 10,000 RYAH Cartridges and QR Codes to an international clinic undertaking one of the world’s largest and most comprehensive clinical trials in plant-based medicine. The initial shipment is designated to be used by the clinic in a pilot run in preparation for the previously announced, UK-based study on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. “We are pleased to bring RYAH’s IoT device and…

Site Search

Company Search

Tag: RYAH Group Inc. RYAH